Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
Related News
Rep. Chuck Edwards Drops Re-election Bid in North Carolina After Ethics Rebuke
Chuck Edwards made the announcement shortly after the House Ethics Committee had recommended he be censured for “persis…
Uber issues weaker-than-expected bookings, earnings forecasts for third quarter
Uber's earnings were in line with estimates, but the company's guidance for the third quarter trailed expectations.
Mortgage rates hit their highest level in over a year, causing demand to drop below year-ago levels
Mortgage rates rose to the highest level in over a year, causing total mortgage demand to drop below year-ago levels.
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patie…
Anthropic's Mythos created fake identities to fool humans in new cyber incident
It's the latest cybersecurity incident involving frontier models developed by Anthropic and OpenAI.
Trump's deportation agenda raised prices, contracted local economies, immigration group says
A report released Wednesday by the immigration advocacy group America's Voice argues President Trump's immigration poli…